BEIJING, May 19 (Xinhua) -- A study by Chinese researchers has found that the COVID-19 booster vaccination can markedly reduce the immune escape of the Omicron variant, underscoring the necessity for the eligible population to get a third booster jab to combat the pandemic. The researchers fro...
Covid-19 booster vaccine jabs for millions of people in England will begin to be offered this week, the NHS has announced. The vaccine will be available to care home residents, people who are 75 and over, and the immunosuppressed aged 12 and over. ...
and our data clearly shows that this additional antigenic exposure produces an extra boost to the overall virus-killing antibody response that is more effective against variants of concern. Our results support the UK Government's plan to provide a booster jab in the autumn as an effective strategy...
More on Covid-19 COVID-19 So, topping up the protection of the over-80s, perhaps along with their flu jab, makes complete sense. They then stand the best chance of remaining fit and well through the winter months when respiratory viruses are more common. The big decision ...
Johnson & Johnson's COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a bigger role as a booster shot. The drugmaker has filed for approval of a second dose of its one-shot Ad26.COV2.S vaccine
The article reports on the announcement by United Kingdom's (UK) Department of Health and Social Care (DHSC) that a COVID-19 booster vaccine and flu jabs will be offered to adult people over 50 years old in the autumn of 2022.Practice Nursing...
The COV-BOOST study looked at safety, immune response (immunogenicity) andside-effects(reactogenicity) of seven vaccines when used as a third booster jab. The vaccines studied were ChAd, BNT, NVX-CoV2373 (Novavax [NVX]), Ad26.COV2.S (Janssen [Ad26]), Moderna [mRNA1273], VLA2001 (Valn...
It's not currently known how long protection lasts from any of the approved vaccines, but most scientists and officials believe that seasonal booster jabs will be required that work in the same way as a seasonal flu jab. In May, the UK government launched a trial looking at seven different...
Unfortunately, the questions surrounding the duration of vaccine-elicited protection and the need for booster injections are currently the focus of ongoing investigations and it is unknown whether booster doses will be needed. Currently, 6 months after the authorization of the COVID-19 vaccines, ...
Moderna aims to roll out a combined COVID-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an annual shot. The single vaccine for COVID-19, influenza andrespiratory syncytial virus—a common virus that causes the...